#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiolitis Hepato-lenticular degeneration Cold type haemolytic anaemia Congenital absence of bile ducts Infantile apnoea Herpes simplex Malignant neoplasm of choroid Bulbospinal muscular atrophy congenital Neuroblastoma recurrent Cervix carcinoma recurrent Retinal dystrophy Leber's congenital amaurosis Hereditary haemorrhagic telangiectasia Adenovirus infection Metastases to peritoneum More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Treatment Inclusion body myositis – Treatment Glycogen storage disease type V – Basic Information Advanced systemic mastocytosis – Treatment Haemophagocytic lymphohistiocytosis – Trials in Disease Focal segmental glomerulosclerosis – Treatment Fragile X syndrome – Diagnostics Primary biliary cholangitis – Life with Disease Sarcoidosis – Life with Disease Malignant fibrous histiocytoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aluminium Mps-102 Ceftriaxone Dmd06-Mab Pd01B 177LU-FAP-2286 Exagamglogene Autotemcel Air, Medicinal Perindopril Arginine Cefuroxime Sodium F770/05 Atorvastatin GSKVX000000040033 Vafidemstat Deupirfenidone Soft Paraffin And Fat Products Ulipristal Acetate Ab-729 Albaconazole Spesolimab More therapies…

    Learn about Your Condition

    Meningococcal infection Psychogenic seizure Brain abscess Radiation skin injury Small cell carcinoma Athetosis Peripheral spondyloarthritis Lung transplant rejection Neuromyopathy Thyroidectomy Squamous cell carcinoma Atrial flutter Facial paresis Anaemia Lichenoid keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • VRDN-003
    Germany Hungary The Netherlands Poland Spain

  • Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • VOROLANIB
    • Aflibercept
    Czechia Germany Hungary Poland Slovakia

  • Title: Study of Sibeprenlimab Treatment for Adults with Sjögren’s Disease Using Subcutaneous Injections

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Sibeprenlimab
    Bulgaria Germany Greece Poland Romania Spain

  • Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Prednisone
    • Tocilizumab
    France

  • Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • ANX007
    Austria Czechia France Germany Hungary Italy +3

  • Study on the Safety and Effectiveness of Timbetasin Acetate Eye Drops for Patients with Neurotrophic Keratopathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Neurotrophic keratopathy
    Investigated Drugs:
    • Timbetasin Acetate
    Italy Poland Spain
Previous Page
1 … 19 20 21 22 23 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!